✦ LIBER ✦

THE EXPRESSION LEVELS OF MMP2, MMP9 IN EXPRESSED PROSTATIC SECRETIONS AS A DISCRIMINATORY MARKER BETWEEN PROSTATE CANCER AND INFLAMMATION

✍ Scribed by Hidas, Guy; Benjamin, Nisman; Gofrit, Ofer N; Yutkin, Vladimir; Duvdevani, Mordechai; Pode, Dov

Book ID: 121938302
Publisher: Lippincott Williams and Wilkins
Year: 2009
Tongue: English
Weight: 46 KB
Volume: 181
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(09)61845-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of plasma MMP-2 and MMP-9 levels as

Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients

✍ Matthew G. Tutton; Mark L. George; Suzanne A. Eccles; Sarah Burton; R. Ian Swift 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 203 KB 👁 1 views

Matrix metalloproteinases, and notably the gelatinases MMP-2 and MMP-9, have important roles in tumour invasion, metastasis and angiogenesis. Our study investigates the distribution of MMP-2 and MMP-9 in colorectal cancer, the correlation with plasma levels, changes following surgical resection and

Expression of matrix metalloproteinases

Expression of matrix metalloproteinases (MMP-2 and -9) and their inhibitors (TIMP-1 and -2) in prostate cancer tissue

✍ Brehmer, B; Biesterfeld, S; Jakse, G 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 240 KB

Antimetastatic potential of fisetin invo

Antimetastatic potential of fisetin involves inactivation of the PI3K/Akt and JNK signaling pathways with downregulation of MMP-2/9 expressions in prostate cancer PC-3 cells

✍ Chi-Sheng Chien; Kun-Hung Shen; Jau-Shyang Huang; Shian-Chin Ko; Yuan-Wei Shih 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 618 KB

672 EXPRESSION OF METALLOPROTEASES (MMPS

672 EXPRESSION OF METALLOPROTEASES (MMPS) AND THEIR INHIBITORS (TIMPS) IN TUMOUR AND STROMAL CELLS AS MARKERS OF RECURRENCE AFTER RADICAL PROSTATECTOMY. UNIVARIATE AND MULTIVARIATE STUDY COMBINED WITH CLUSTER ANALYSIS OF THE PROTEIN EXPRESSION IN PROSTATE CANCER TISSUE ARRAY SAMPLES

✍ J.M. Fernandez-Gomez; S. Escaf; L.O. Gonzalez; A. Suarez; S. Gonzalez-Reyes; S. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Characterization of the expression of va

Characterization of the expression of variant and standard CD44 in prostate cancer cells: Identification of the possible molecular mechanism of CD44/MMP9 complex formation on the cell surface

✍ B. Desai; T. Ma; J. Zhu; M.A. Chellaiah 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 593 KB

## Abstract CD44 is a glycosylated adhesion molecule and osteopontin is one of its ligand. CD44 undergoes alternative splicing to produce variant isoforms. Our recent studies have shown an increase in the surface expression of CD44 isoforms (sCD44 and v4–v10 variant CD44) in prostate cancer cells o

Dissociation between androgen responsive

Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models. Denmeade SR, Sokoll LJ, Dalrymple S, Rosen DM, Gady AM, Bruzek D, Ricklis RM, Isaacs JT, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231: Prostate 2003;54(4):249–257

✍ Maarten Bosland 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 21 KB